Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)

Authors: Carlos M. Barrera, Analía Mykietiuk, Hristo Metev, Mimi Niţu, Najumuddin Karimjee, Pablo Alexis Doreski, Ismail Mitha, Cristina Tănăseanu, Joseph M Molina, Yuri Antonovsky, Dirkie Johanna Van Rensburg, Brian H. Rowe, Jose Flores‐Figueroa, Barbara Rewerska, Kay Clark, Kara Keedy, Amanda Sheets, Drusilla Scott, Gary Horwith, Anita Das, Brian Jamieson, Prabhavathi Fernandes, David Oldach - The Lancet 2016 cited by 101